MeSci
Senior Member (Voting Rights)
I think this is new:
http://www.investinme.org/IIMER-Newslet-1802-01.shtml
February 2018
Rituximab Trial and Research
Statement Following Preliminary Phase III Rituximab Clinical trial Results from Norway
Following the preliminary results which Professor Olav Mella recently publicly released from the Phase III multi-centre double-blinded placebo-controlled Rituximab Clinical Trial (see statement 21st November 2017) the charity has had discussions with advisors and researchers and has now received further communication from Dr Fluge in Norway.
Invest in ME Research has issued the statement below regarding the planned UK trial.
The Haukeland team will be presenting at the IIMEC13 13th International ME Conference in London on 1st June 2018
More at link.
http://www.investinme.org/IIMER-Newslet-1802-01.shtml
February 2018
Rituximab Trial and Research
Statement Following Preliminary Phase III Rituximab Clinical trial Results from Norway
Following the preliminary results which Professor Olav Mella recently publicly released from the Phase III multi-centre double-blinded placebo-controlled Rituximab Clinical Trial (see statement 21st November 2017) the charity has had discussions with advisors and researchers and has now received further communication from Dr Fluge in Norway.
Invest in ME Research has issued the statement below regarding the planned UK trial.
The Haukeland team will be presenting at the IIMEC13 13th International ME Conference in London on 1st June 2018
More at link.